BANVT.E — Banvit Bandirma Vitaminli Yem Sanayi AS Income Statement
0.000.00%
- TRY17.95bn
- TRY14.48bn
- TRY31.53bn
Annual income statement for Banvit Bandirma Vitaminli Yem Sanayi AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,678 | 5,321 | 20,274 | 30,789 | 31,534 |
| Cost of Revenue | |||||
| Gross Profit | 223 | 680 | -516 | 3,653 | 7,390 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,860 | 5,144 | 22,563 | 30,317 | 26,763 |
| Operating Profit | -182 | 178 | -2,289 | 471 | 4,770 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -248 | 118 | -938 | 2,034 | 5,146 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -200 | 95.2 | -952 | 1,446 | 3,599 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -200 | 95.2 | -983 | 1,374 | 3,599 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -200 | 95.2 | -983 | 1,374 | 3,599 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.56 | 0.12 | -9.52 | 14.5 | 36 |
| Dividends per Share |